UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 221

Sortiert nach

Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease

The New England journal of medicine, 2022-02, Vol.386 (7), p.617-628

2022

Link zum Volltext

Verfügbarkeit prüfen

Tolerance and Cancer: Mechanisms of Tumor Evasion and Strategies for Breaking Tolerance

Journal of clinical oncology, 2004-03, Vol.22 (6), p.1136-1151

2004

Link zum Volltext

Verfügbarkeit prüfen

Targeting the GCK pathway: a novel and selective therapeutic strategy against RAS-mutated multiple myeloma

Blood, 2021-04, Vol.137 (13), p.1754-1764

2021

Link zum Volltext

Verfügbarkeit prüfen

The checkpoint inhibitor PD-1H/VISTA controls osteoclast-mediated multiple myeloma bone disease

Nature communications, 2023-07, Vol.14 (1), p.4271-4271, Article 4271

2023

Link zum Volltext

Verfügbarkeit prüfen

IFN-γR/STAT1 signaling in recipient hematopoietic antigen-presenting cells suppresses graft-versus-host disease

The Journal of clinical investigation, 2023-02, Vol.133 (3)

2023

Link zum Volltext

Verfügbarkeit prüfen

Janus Kinase Inhibitors and Cell Therapy

Frontiers in immunology, 2021-08, Vol.12, p.740847-740847

2021

Link zum Volltext

Verfügbarkeit prüfen

Dendritic cells and regulation of graft-versus-host disease and graft-versus-leukemia activity

Blood, 2012-05, Vol.119 (22), p.5088-5103

2012

Link zum Volltext

Verfügbarkeit prüfen

The prospect of universal coronavirus immunity: characterization of reciprocal and non-reciprocal T cell responses against SARS-CoV2 and common human coronaviruses

Frontiers in immunology, 2023-10, Vol.14, p.1212203-1212203

2023

Link zum Volltext

Verfügbarkeit prüfen

The histone deacetylase inhibitor, PXD101, potentiates bortezomib‐induced anti‐multiple myeloma effect by induction of oxidative stress and DNA damage

British journal of haematology, 2007-11, Vol.139 (3), p.385-397

2007

Link zum Volltext

Verfügbarkeit prüfen

Thalidomide derivative CC-4047 inhibits osteoclast formation by down-regulation of PU.1

Blood, 2006-04, Vol.107 (8), p.3098-3105

2006

Link zum Volltext

Verfügbarkeit prüfen

Immunomodulatory derivatives induce PU.1 down-regulation, myeloid maturation arrest, and neutropenia

Blood, 2010-01, Vol.115 (3), p.605-614

2010

Link zum Volltext

Verfügbarkeit prüfen

Amplification of Signal on Cell Surfaces in Molecular Cascades

Cells (Basel, Switzerland), 2023-12, Vol.12 (24), p.2858

2023

Link zum Volltext

Verfügbarkeit prüfen

CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia

The New England journal of medicine, 2021-01, Vol.384 (3), p.252-260

2021

Link zum Volltext

Verfügbarkeit prüfen

Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen–presenting cells

Blood, 2002-09, Vol.100 (5), p.1903-1909

2002

Link zum Volltext

Verfügbarkeit prüfen

Macrophage inflammatory protein 1-alpha (MIP-1α) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma (MM) cells

Blood, 2003-05, Vol.101 (9), p.3568-3573

2003

Link zum Volltext

Verfügbarkeit prüfen

First report of outcomes in patients with stage IIIb AL amyloidosis treated with Dara–VCD front‐line therapy

British journal of haematology, 2023-06, Vol.201 (5), p.913-916

2023

Link zum Volltext

Verfügbarkeit prüfen

Absence of Stat1 in donor CD4+ T cells promotes the expansion of Tregs and reduces graft-versus-host disease in mice

The Journal of clinical investigation, 2024-03, Vol.134 (5)

2024

Link zum Volltext

Verfügbarkeit prüfen

Histopathology of Graft-vs-Host Disease of Gastrointestinal Tract and Liver: An Update

American journal of clinical pathology, 2016-05, Vol.145 (5), p.591-603

2016

Link zum Volltext

Verfügbarkeit prüfen

High-dose melphalan-autologous hematopoietic cell transplantation in systemic AL amyloidosis following daratumumab-based frontline therapy

Bone marrow transplantation (Basingstoke), 2024-05

2024

Link zum Volltext

Verfügbarkeit prüfen

IMiD compounds affect CD34+ cell fate and maturation via CRBN-induced IKZF1 degradation

Blood advances, 2018-03, Vol.2 (5), p.492-504

2018

Link zum Volltext

Verfügbarkeit prüfen

Psychiatric comorbidities in adults with sickle cell disease: A narrative review

British journal of haematology, 2023-12, Vol.203 (5), p.747-759

2023

Link zum Volltext

Verfügbarkeit prüfen

KD5170, a novel mercaptoketone-based histone deacetylase inhibitor, exerts antimyeloma effects by DNA damage and mitochondrial signaling

Molecular cancer therapeutics, 2008-06, Vol.7 (6), p.1494-1505

2008

Link zum Volltext

Verfügbarkeit prüfen

Chimeric antigen receptor T cells for treatment of transformed Waldenström macroglobulinemia

Leukemia & lymphoma, 2020-01, Vol.61 (2), p.465-468

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 221

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(197)
Mit Volltextzugriff
(216)

Publikationsform

Sprache

Englisch
(221)
Japanisch
(22)

Erscheinungsjahr

n.n

Thema

Science & Technology
(78)
Life Sciences & Biomedicine
(77)
Humans
(61)
Hematology
(45)
Female
(32)
Animals
(28)
Immunology
(27)
Biological And Medical Sciences
(24)
Mice
(24)
Medical Sciences
(23)
Oncology
(20)
Male
(19)
Adult
(17)
Middle Aged
(14)
Transplantation
(14)
Apoptosis
(13)
Tumor Cells, Cultured
(13)
Medicine, Research & Experimental
(12)
Research & Experimental Medicine
(12)
Hematologic And Hematopoietic Diseases
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease

Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial

Tolerance and Cancer: Mechanisms of Tumor Evasion and Strategies for Breaking Tolerance

Targeting the GCK pathway: a novel and selective therapeutic strategy against RAS-mutated multiple myeloma

The checkpoint inhibitor PD-1H/VISTA controls osteoclast-mediated multiple myeloma bone disease

IFN-γR/STAT1 signaling in recipient hematopoietic antigen-presenting cells suppresses graft-versus-host disease

Janus Kinase Inhibitors and Cell Therapy

Dendritic cells and regulation of graft-versus-host disease and graft-versus-leukemia activity

Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trial

The prospect of universal coronavirus immunity: characterization of reciprocal and non-reciprocal T cell responses against SARS-CoV2 and common human coronaviruses

The histone deacetylase inhibitor, PXD101, potentiates bortezomib‐induced anti‐multiple myeloma effect by induction of oxidative stress and DNA damage

Thalidomide derivative CC-4047 inhibits osteoclast formation by down-regulation of PU.1

Immunomodulatory derivatives induce PU.1 down-regulation, myeloid maturation arrest, and neutropenia

Amplification of Signal on Cell Surfaces in Molecular Cascades

CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia

Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen–presenting cells

Macrophage inflammatory protein 1-alpha (MIP-1α) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma (MM) cells

First report of outcomes in patients with stage IIIb AL amyloidosis treated with Dara–VCD front‐line therapy

Absence of Stat1 in donor CD4+ T cells promotes the expansion of Tregs and reduces graft-versus-host disease in mice

Histopathology of Graft-vs-Host Disease of Gastrointestinal Tract and Liver: An Update

High-dose melphalan-autologous hematopoietic cell transplantation in systemic AL amyloidosis following daratumumab-based frontline therapy

IMiD compounds affect CD34+ cell fate and maturation via CRBN-induced IKZF1 degradation

Psychiatric comorbidities in adults with sickle cell disease: A narrative review

KD5170, a novel mercaptoketone-based histone deacetylase inhibitor, exerts antimyeloma effects by DNA damage and mitochondrial signaling

Chimeric antigen receptor T cells for treatment of transformed Waldenström macroglobulinemia

Suchergebnisse filtern